| Common Name: | TRIPLE ANTIBIOTIC OINTMENT |
| Manufacturer: | WATER-JEL TECHNOLOGIES |
| SDS Revision Date: | 9/16/2011 |
| SDS Format: | No Format Specified |
| Item Number(s): | 1PBZ7, 1PBZ9, 1PCC4, 1PCC6, 1PCZ6, 21R520, 2AC62, 3UCH8, 3WHT9, 5DXY6, 5ELU4, 5ELU5, 8CWM4, 8TRE8, 9DY58, 9WZG0 |
| Manufacturer Model Number(s): |
SDS Table of Contents
Click the desired link below to jump directly to that section in the SDS.
MATERIAL SAFETY DATA SHEET
WATEr-JEL(R*) TECHNOLOGIES
ISSUING DATE: 16-SEP-2011
REVISION DATE:
REVISION NUMBER: 0
| 1. PRODUCT AND COMPANY IDENTIFICATION |  |
PRODUCT NAME: TRIPLE ANTIBIOTIC OINTMENT
PRODUCT CODE(S): TA.50.121
RECOMMENDED USE: FIRST AID ANTIBIOTIC OINTMENT, FIRST AID ANTIBIOTIC CREAM
SUPPLIER ADDRESS:
WATER-JEL TECHNOLOGIES
50 BROAD ST.
CARLSTADT, NJ 07072
TEL: (201) 507-8300
EMERGENCY TELEPHONE NUMBER: (201) 507-8300
| 2. HAZARDS IDENTIFICATION | |
WARNING!
EMERGENCY OVERVIEW:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY BE HARMFUL IF SWALLOWED
MAY PRODUCE AN ALLERGIC REACTION
MAY CAUSE SKIN IRRITATION AND/OR DERMATITIS
OCCUPATIONAL RESTRICTIONS FOR PREGNANT AND BREAST FEEDING WOMEN
APPEARANCE: OFF-WHITE
PHYSICAL STATE: SEMI-SOLID OINTMENT.
ODOR: NO INFORMATION AVAILABLE
POTENTIAL HEALTH EFFECTS:
ACUTE TOXICITY:
EYES: MAY CAUSE IRRITATION.
SKIN:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY CAUSE SKIN IRRITATION AND/OR DERMATITIS. REPEATED OR PROLONGED SKIN
CONTACT MAY CAUSE ALLERGIC REACTIONS WITH SUSCEPTIBLE PERSONS.
INHALATION: NOT AN EXPECTED ROUTE OF EXPOSURE.
INGESTION:
NOT AN EXPECTED ROUTE OF EXPOSURE. DO NOT INGEST. MAY BE HARMFUL IF
SWALLOWED. INGESTION MAY CAUSE GASTROINTESTINAL IRRITATION, NAUSEA,
VOMITING AND DIARRHEA.
CHRONIC EFFECTS:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY PRODUCE AN ALLERGIC REACTION. MAY CAUSE ADVERSE LIVER AND KIDNEY
EFFECTS. CONTAINS A KNOWN OR SUSPECTED REPRODUCTIVE TOXIN.
NURSING MOTHERS:
THERE ARE NO DATA ON THE EXCRETION OF NEOMYCIN, AN AMINOGLYCOSIDE INTO
HUMAN MILK. OTHER AMINOGLYCOSIDES ARE EXCRETED INTO HUMAN MILK.
AGGRAVATED MEDICAL CONDITIONS:
ALLERGIES. SKIN DISORDERS. RESPIRATORY DISORDERS. LIVER DISORDERS. KIDNEY
DISORDERS.
INTERACTIONS WITH OTHER CHEMICALS: IRRITANTS. SENSITIZERS. EPOXIES.
ENVIRONMENTAL HAZARD:
SEE SECTION 12 FOR ADDITIONAL ECOLOGICAL INFORMATION.
| 3. COMPOSITION/INFORMATION ON INGREDIENTS | |
CHEMICAL NAME CAS-NO WEIGHT %
PETROLATUM (USP GRADE) 8009-03-8 60-100
BACITRACIN ZINC USP MICRONIZED 1405-89-6 <1
NEOMYCIN SULFATE USP MICRONIZED 1405-10-3 <1
POLYMYXIN B, SULFATE (SALT) 1405-20-5 <1
NOTE:
THIS SECTION LISTS OSHA AND WHMIS HAZARDOUS CHEMICALS AT OR ABOVE THRESHOLD
AS WELL AS ACTIVE PHARMACEUTICAL INGREDIENTS. FOR A FULL LIST OF
INGREDIENTS, PLEASE SEE PRODUCT PACKAGING.
| 4. FIRST AID MEASURES | |
EYE CONTACT:
RINSE IMMEDIATELY WITH PLENTY OF WATER, ALSO UNDER THE EYELIDS, FOR AT
LEAST 15 MINUTES. IF SYMPTOMS PERSIST, CALL A PHYSICIAN.
SKIN CONTACT:
WASH SKIN WITH SOAP AND WATER. IN THE CASE OF SKIN IRRITATION OR ALLERGIC
REACTIONS SEE A PHYSICIAN.
INHALATION:
NONE UNDER NORMAL USE. MOVE TO FRESH AIR IN CASE OF ACCIDENTAL INHALATION
OF VAPORS OR DECOMPOSITION PRODUCTS. IF SYMPTOMS PERSIST, CALL A PHYSICIAN.
INGESTION:
DO NOT INDUCE VOMITING. RINSE MOUTH. DRINK PLENTY OF WATER. CONSULT A
PHYSICIAN.
NOTES TO PHYSICIAN:
TREAT SYMPTOMATICALLY. MAY CAUSE SENSITIZATION BY SKIN CONTACT.
PROTECTION OF FIRST-AIDERS:
ENSURE THAT MEDICAL PERSONNEL ARE AWARE OF THE MATERIAL(S) INVOLVED, AND
TAKE PRECAUTIONS TO PROTECT THEMSELVES.
| 5. FIRE-FIGHTING MEASURES | |
FLAMMABLE PROPERTIES: NOT FLAMMABLE.
FLASH POINT: NOT APPLICABLE.
SUITABLE EXTINGUISHING MEDIA:
USE EXTINGUISHING MEASURES THAT ARE APPROPRIATE TO LOCAL CIRCUMSTANCES AND
THE SURROUNDING ENVIRONMENT.
EXPLOSION DATA:
SENSITIVITY TO MECHANICAL IMPACT: NONE
SENSITIVITY TO STATIC DISCHARGE: NONE
SPECIFIC HAZARDS ARISING FROM THE CHEMICAL:
MAY CAUSE SENSITIZATION BY SKIN CONTACT.
PROTECTIVE EQUIPMENT AND PRECAUTIONS FOR FIREFIGHTERS:
AS IN ANY FIRE, WEAR SELF-CONTAINED BREATHING APPARATUS PRESSURE-DEMAND,
MSHA/NIOSH (APPROVED OR EQUIVALENT) AND FULL PROTECTIVE GEAR.
NFPA:
HEALTH HAZARD 2
FLAMMABILITY 0
INSTABILITY 0
PHYSICAL AND CHEMICAL HAZARDS
HMIS:
HEALTH HAZARD 2*
FLAMMABILITY 0
PHYSICAL HAZARD 0
PERSONAL PROTECTION B
*INDICATES A CHRONIC HEALTH HAZARD.
| 6. ACCIDENTAL RELEASE MEASURES | |
PERSONAL PRECAUTIONS: AVOID CONTACT WITH THE SKIN AND THE EYES.
ENVIRONMENTAL PRECAUTIONS:
REFER TO PROTECTIVE MEASURES LISTED IN SECTIONS 7 AND 8.
METHODS FOR CONTAINMENT:
PREVENT FURTHER LEAKAGE OR SPILLAGE IF SAFE TO DO SO.
METHODS FOR CLEANING UP:
COVER LIQUID SPILL WITH SAND, EARTH OR OTHER NONCOMBUSTIBLE ABSORBENT
MATERIAL. PICK UP AND TRANSFER TO PROPERLY LABELED CONTAINERS.
| 7. HANDLING AND STORAGE | |
HANDLING:
HANDLE IN ACCORDANCE WITH GOOD INDUSTRIAL HYGIENE AND SAFETY PRACTICE.
STORAGE:
KEEP AT CONTROLLED ROOM TEMPERATURE. KEEP AT TEMPERATURES BETWEEN 15 AND 25
DEG. C (59 AND 77 DEG. F). PROTECT FROM FREEZING. KEEP OUT OF THE REACH OF
CHILDREN.
| 8. EXPOSURE CONTROLS / PERSONAL PROTECTION | |
EXPOSURE GUIDELINES:
THIS PRODUCT DOES NOT CONTAIN ANY HAZARDOUS MATERIALS WITH OCCUPATIONAL
EXPOSURE LIMITS ESTABLISHED BY THE REGION SPECIFIC REGULATORY BODIES.
ENGINEERING MEASURES:
SHOWERS
EYEWASH STATIONS
VENTILATION SYSTEMS
PERSONAL PROTECTIVE EQUIPMENT:
EYE/FACE PROTECTION:
WHEN WORKING WITH BULK PRODUCT, SAFETY GLASSES WITH SIDE SHIELDS. NO
PROTECTIVE EQUIPMENT IS NEEDED UNDER NORMAL USE CONDITIONS.
SKIN AND BODY PROTECTION:
NO PROTECTIVE EQUIPMENT IS NEEDED UNDER NORMAL USE CONDITIONS.
RESPIRATORY PROTECTION:
NO PROTECTIVE EQUIPMENT IS NEEDED UNDER NORMAL USE CONDITIONS.
HYGIENE MEASURES:
HANDLE IN ACCORDANCE WITH GOOD INDUSTRIAL HYGIENE AND SAFETY PRACTICE.
| 9. PHYSICAL AND CHEMICAL PROPERTIES | |
APPEARANCE: OFF-WHITE.
ODOR: NO INFORMATION AVAILABLE
ODOR THRESHOLD: NO INFORMATION AVAILABLE
PHYSICAL STATE: SEMI-SOLID OINTMENT
pH: NO INFORMATION AVAILABLE.
FLASH POINT: NOT APPLICABLE.
AUTOIGNITION TEMPERATURE: NO INFORMATION AVAILABLE.
DECOMPOSITION TEMPERATURE: NO INFORMATION AVAILABLE.
BOILING POINT/BOILING RANGE: NO INFORMATION AVAILABLE
MELTING POINT/RANGE: NO INFORMATION AVAILABLE
FLAMMABILITY LIMITS IN AIR: NO INFORMATION AVAILABLE.
EXPLOSION LIMITS: NO INFORMATION AVAILABLE.
SPECIFIC GRAVITY: 0.855
SOLUBILITY: NO INFORMATION AVAILABLE.
EVAPORATION RATE: NO INFORMATION AVAILABLE
VAPOR PRESSURE: NO DATA AVAILABLE.
VAPOR DENSITY: NO DATA AVAILABLE.
| 10. STABILITY AND REACTIVITY | |
STABILITY: STABLE UNDER RECOMMENDED STORAGE CONDITIONS.
INCOMPATIBLE PRODUCTS: OXIDIZING AGENTS. REDUCING AGENTS.
CONDITIONS TO AVOID: PROTECT FROM LIGHT.
HAZARDOUS DECOMPOSITION PRODUCTS: CARBON OXIDES. NITROGEN OXIDES (NOx).
HAZARDOUS POLYMERIZATION: HAZARDOUS POLYMERIZATION DOES NOT OCCUR.
| 11. TOXICOLOGICAL INFORMATION | |
ACUTE TOXICITY:
PRODUCT INFORMATION:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY BE HARMFUL IF SWALLOWED. MAY CAUSE EYE AND SKIN IRRITATION.
CHEMICAL NAME LD50 ORAL LD50 DERMAL LC50 INHALATION
PETROLATUM (USP GRADE) >3600 MG/KG (RABBIT)
CHRONIC TOXICITY:
CHRONIC TOXICITY:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY PRODUCE AN ALLERGIC REACTION. MAY CAUSE ADVERSE LIVER AND KIDNEY
EFFECTS. CONTAINS A KNOWN OR SUSPECTED REPRODUCTIVE TOXIN.
NURSING MOTHERS:
THERE ARE NO DATA ON THE EXCRETION OF NEOMYCIN, AN AMINOGLYCOSIDE INTO
HUMAN MILK. OTHER AMINOGLYCOSIDES ARE EXCRETED INTO HUMAN MILK.
CARCINOGENICITY:
CONTAINS NO INGREDIENTS ABOVE REPORTABLE QUANTITIES LISTED AS A CARCINOGEN.
SENSITIZATION: MAY CAUSE SENSITIZATION OF SUSCEPTIBLE PERSONS.
DEVELOPMENTAL TOXICITY:
NEOMYCIN HAS BEEN ASSIGNED TO PREGNANCY CATEGORY D (THERE IS POSITIVE
EVIDENCE OF HUMAN FETAL RISK BASED ON ADVERSE REACTION DATA FROM
INVESTIGATIONAL OR MARKETING EXPERIENCE OR STUDIES IN HUMANS, BUT POTENTIAL
BENEFITS MAY WARRANT USE OF THE DRUG IN PREGNANT WOMEN DESPITE POTENTIAL
RISKS.)
TARGET ORGAN EFFECTS:
SKIN. LIVER. KIDNEY. CONTAINS MATERIAL THAT MAY ADVERSELY AFFECT THE
DEVELOPING FETUS. PERIPHERAL NERVOUS SYSTEM (PNS)
| 12. ECOLOGICAL INFORMATION | |
ECOTOXICITY:
THE ENVIRONMENTAL IMPACT OF THIS PRODUCT HAS NOT BEEN FULLY INVESTIGATED.
ECOTOXICITY EFFECTS OF COMPONENT SUBSTANCES.
CHEMICAL NAME TOXICITY TO TOXICITY TO TOXICITY TO DAPHNIA MAGNA
ALGAE FISH MICROORGANISMS (WATER FLEA)
BACITRACIN ZINC LC50:
USP MICRONIZED 30.48 MG/L
(48-HR)
| 13. DISPOSAL CONSIDERATIONS | |
WASTE DISPOSAL METHODS:
THIS MATERIAL, AS SUPPLIED, IS NOT A HAZARDOUS WASTE ACCORDING TO FEDERAL
REGULATIONS (40 CFR 261). THIS MATERIAL COULD BECOME A HAZARDOUS WASTE IF
IT IS MIXED WITH OR OTHERWISE COMES IN CONTACT WITH A HAZARDOUS WASTE, IF
CHEMICAL ADDITIONS ARE MADE TO THIS MATERIAL, OR IF THE MATERIAL IS
PROCESSED OR OTHERWISE ALTERED. CONSULT 40 CFR 261 TO DETERMINE WHETHER THE
ALTERED MATERIAL IS A HAZARDOUS WASTE. CONSULT THE APPROPRIATE STATE,
REGIONAL, OR LOCAL REGULATIONS FOR ADDITIONAL REQUIREMENTS.
CONTAMINATED PACKAGING: DO NOT RE-USE EMPTY CONTAINERS.
CALIFORNIA HAZARDOUS WASTE CODES: 311
CALIFORNIA WASTE CODE LEGEND: PHARMACEUTICAL WASTE
THIS PRODUCT CONTAINS ONE OR MORE SUBSTANCES THAT ARE LISTED WITH THE STATE
OF CALIFORNIA AS A HAZARDOUS WASTE.
CHEMICAL NAME CALIFORNIA HAZARDOUS WASTE
BACITRACIN ZINC USP MICRONIZED TOXIC
| 14. TRANSPORT INFORMATION | |
DOT: NOT REGULATED
TDG: NOT REGULATED
MEX: NOT REGULATED
IATA: NOT REGULATED
IMDG/IMO: NOT REGULATED
| 15. REGULATORY INFORMATION | |
INTERNATIONAL INVENTORIES:
TSCA: EXEMPT
DSL: EXEMPT
LEGEND:
TSCA: UNITED STATES TOXIC SUBSTANCES CONTROL ACT SECTION 8(B) INVENTORY
DSL/NDSL: CANADIAN DOMESTIC SUBSTANCES LIST/NON-DOMESTIC SUBSTANCES LIST
U.S. FEDERAL REGULATIONS:
SECTION 313 OF TITLE III OF THE SUPERFUND AMENDMENTS AND REAUTHORIZATION
ACT OF 1986 (SARA). THIS PRODUCT DOES NOT CONTAIN ANY CHEMICALS WHICH ARE
SUBJECT TO THE REPORTING REQUIREMENTS OF THE ACT AND TITLE 40 OF THE CODE
OF FEDERAL REGULATIONS, PART 372.
SARA 311/312 HAZARD CATEGORIES:
ACUTE HEALTH HAZARD: EXEMPT
CHRONIC HEALTH HAZARD: EXEMPT
FIRE HAZARD: EXEMPT
REACTIVE HAZARD: EXEMPT
SUDDEN RELEASE OF PRESSURE HAZARD: EXEMPT
THIS IS AN FDA REGULATED PRODUCT AND AS SUCH IS EXEMPTED FROM SARA TIER II
REPORTING.
CLEAN WATER ACT:
THIS PRODUCT DOES NOT CONTAIN ANY SUBSTANCES REGULATED AS POLLUTANTS
PURSUANT TO THE CLEAN WATER ACT (40 CFR 122.21 AND 40 CFR 122.42).
CERCLA:
THIS MATERIAL, AS SUPPLIED, DOES NOT CONTAIN ANY SUBSTANCES REGULATED AS
HAZARDOUS SUBSTANCES UNDER THE COMPREHENSIVE ENVIRONMENTAL RESPONSE
COMPENSATION AND LIABILITY ACT (CERCLA) (40 CFR 302) OR THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) (40 CFR 355). THERE MAY BE
SPECIFIC REPORTING REQUIREMENTS AT THE LOCAL, REGIONAL, OR STATE LEVEL
PERTAINING TO RELEASES OF THIS MATERIAL.
U.S. STATE REGULATIONS:
CALIFORNIA PROPOSITION 65:
THIS PRODUCT CONTAINS THE FOLLOWING PROPOSITION 65 CHEMICALS:
CHEMICAL NAME CAS-NO CALIFORNIA PROP. 65
NEOMYCIN SULFATE USP MICRONIZED 1405-10-3 DEVELOPMENTAL
U.S. STATE RIGHT-TO-KNOW REGULATIONS:
"X" DESIGNATES THAT THE INGREDIENTS ARE LISTED ON THE STATE RIGHT TO KNOW
LIST.
CHEMICAL NAME NEW JERSEY MASSACHUSETTS PENNSYLVANIA ILLINOIS RHODE
ISLAND
BACITRACIN ZINC X X
INTERNATIONAL REGULATIONS:
CANADA:
THIS PRODUCT IS REGULATED BY THE FOOD AND DRUG ADMINISTRATION OF HEALTH
CANADA AND IS NOT SUBJECT TO THE WHMIS REQUIREMENTS OF THE HAZARDOUS
PRODUCTS ACT AND THE CONTROLLED PRODUCTS REGULATIONS.
| 16. OTHER INFORMATION | |
PREPARED BY:
PRODUCT STEWARDSHIP
23 BRITISH AMERICAN BLVD.
LATHAM, NY 12110
1-800-572-6501
ISSUING DATE: 16-SEP-2011
REVISION DATE:
REVISION NOTE: INITIAL RELEASE.
GENERAL DISCLAIMER:
THE INFORMATION PROVIDED ON THIS MSDS IS CORRECT TO THE BEST OF OUR
KNOWLEDGE, INFORMATION AND BELIEF AT THE DATE OF ITS PUBLICATION. THE
INFORMATION GIVEN IS DESIGNED ONLY AS A GUIDE FOR SAFE HANDLING, USE,
PROCESSING, STORAGE, TRANSPORTATION, DISPOSAL AND RELEASE AND IS NOT TO BE
CONSIDERED AS A WARRANTY OR QUALITY SPECIFICATION. THE INFORMATION RELATES
ONLY TO THE SPECIFIC MATERIAL DESIGNATED AND MAY NOT BE VALID FOR SUCH
MATERIAL USED IN COMBINATION WITH ANY OTHER MATERIAL OR IN ANY PROCESS,
UNLESS SPECIFIED IN THE TEXT.
WPS-WJT-001 - TRIPLE ANTIBIOTIC OINTMENT